|
1 Indications And Usage Fosaprepitant For Injection, In Combination With Other Antiemetic Agents, Is Indicated In Adults For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Limitations Of Use Fosaprepitant For Injection Has Not Been Studied For The Treatment Of Established Nausea And Vomiting. Fosaprepitant For Injection Is A Substance P/neurokinin-1 (Nk 1 ) Receptor Antagonist, Indicated In Adults, In Combination With Other Antiemetic Agents, For The Prevention Of ( 1 ): Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Limitations Of Use ( 1 ) Fosaprepitant For Injection Has Not Been Studied For Treatment Of Established Nausea And Vomiting.
|